Key result
Thrombophilia risk factors were present in 29% of women with pregnancy-associated complications, most frequently linked with venous thromboembolism and foetal death.
Why the study?
Are thrombophilia risk factors associated with pregnancy-related complications such as foetal death and venous thromboembolism?
Observational (n=414)
Are thrombophilia risk factors associated with pregnancy-related complications such as foetal death and venous thromboembolism?
Thrombophilia risk factors, particularly Factor V Leiden and antiphospholipid antibodies, are highly prevalent in women with pregnancy-associated complications such as venous thromboembolism and foetal loss.
Answers are grounded in this paper and cite their sources.
Should not yet alter management of pregnancy complications; leaves open whether thrombophilia screening improves outcomes in prospective trials.
Pregnancy in healthy women is accompanied by hypercoagulable changes that may interact with thrombophilia risk factors and threaten pregnancy. However, the literature on this issue is conflicting. In investigating the relationship between pregnancy-associated complications and the presence of thrombophilia risk factors, we studied the records of 414 women who had been examined for inherited and acquired thrombophilia in the period 1996 to 2006 because of pregnancy-associated complications. Of a total of 885 pregnancies among the women, 397 were recorded as foetal loss/intrauterine foetal death during the first (62 %), second (25 %) or third trimester (13 %). One-hundred-and-two (25 %) women had had a thromboembolic event during one of their pregnancies, and 98 (24 %) had had pre-eclampsia on at least one occasion. Intrauterine growth restriction was found in 105 (25 %) of the women, and 29 (7 %) suffered placental abruption. We found that 120 (29 %) women had at least one thrombophilia risk factor. Factor V Leiden heterozygosity was the most common thrombophilia factor (n = 52), mostly linked with the risk of venous thromboembolism during pregnancy or postpartum and to foetal death during the second or third trimester. Fifty-three (13 %) women had antiphospholipid antibodies (lupus anticoagulant and/or anti-beta2-glycoprotein 1 antibodies) mainly associated with the risk of spontaneous abortion during the first trimester. In conclusion, thrombophilia was found to be considerably more common in women with pregnancy-associated complications in comparison with the general population, and most frequently in conjunction with venous thromboembolism during pregnancy and the postpartum period.
No takes yet. Share an insight, caveat, or question.
Hvas et al. (2008) conducted an observational in Pregnancy-associated complications (n=414). Thrombophilia risk factors vs. General population was evaluated on Pregnancy-associated complications. Thrombophilia risk factors were present in 29% of women with pregnancy-associated complications, most frequently linked with venous thromboembolism and foetal death.
Synapse has enriched 10 related papers. Consider them for comparative context: